The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …

Allogeneic hematopoietic cell transplantation involves consideration of both donor and
recipient characteristics to guide the selection of a suitable graft. Sufficient high-resolution …

PURPOSE Calcineurin inhibitors (CNI) are standard components of graft-versus-host
disease (GVHD) prophylaxis after hematopoietic cell transplantation (HCT). Prior data …

Relapse after allogeneic hematopoietic cell transplantation (HCT) is the leading cause of
death in patients with acute myeloid leukemia (AML) entering HCT with poor-risk features …

Acute Myeloid Leukemia | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

We studied adults with acute myeloid leukemia (AML) after haploidentical (n= 192) and 8/8
HLA-matched unrelated donor (n= 1982) transplantation. Haploidentical recipients received …

Background Chronic graft-versus-host disease (GVHD) is the leading cause of later illness
and death after allogeneic hematopoietic stem-cell transplantation. We hypothesized that …

Background The majority of patients in need of a hematopoietic-cell transplant do not have a
matched related donor. Data are needed to inform the choice among various alternative …

Purpose The major causes of mortality after allogeneic hematopoietic-cell transplantation
(allo-HCT) are relapse, graft-versus-host disease (GVHD), and infection. We have reported …

Purpose T-cell–replete HLA-haploidentical donor hematopoietic transplantation using post-
transplant cyclophosphamide was originally described using bone marrow (BM). With …